PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 86 filers reported holding PASSAGE BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,597 | -94.8% | 10,026 | -92.5% | 0.00% | – |
Q2 2023 | $126,407 | -51.9% | 134,290 | -51.0% | 0.00% | – |
Q1 2023 | $262,731 | -47.5% | 274,335 | -24.4% | 0.00% | -100.0% |
Q4 2022 | $500,598 | +5.6% | 362,752 | -4.3% | 0.00% | 0.0% |
Q3 2022 | $474,000 | -44.6% | 379,136 | +4.6% | 0.00% | 0.0% |
Q2 2022 | $855,000 | -8.3% | 362,356 | +20.5% | 0.00% | 0.0% |
Q1 2022 | $932,000 | +8.0% | 300,732 | +121.3% | 0.00% | 0.0% |
Q4 2021 | $863,000 | – | 135,904 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 2,497,922 | $1,648,629 | 2.12% |
Versant Venture Management, LLC | 4,959,769 | $3,263,528 | 1.74% |
BML Capital Management, LLC | 2,058,767 | $1,354,669 | 1.24% |
Acuitas Investments, LLC | 418,161 | $275,150 | 0.16% |
Orbimed Advisors | 10,124,576 | $6,661,971 | 0.14% |
Lynx1 Capital Management LP | 190,124 | $125,102 | 0.08% |
Frazier Life Sciences Management, L.P. | 1,758,219 | $1,156,908 | 0.08% |
TANG CAPITAL MANAGEMENT LLC | 400,000 | $263,200 | 0.04% |
Marquette Asset Management, LLC | 86,050 | $56,621 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 506,600 | $333,343 | 0.01% |